SURROGATE, FRIEND OR FOE? THE NEED FOR CASE STUDIES OF THE USE OF SURROGATE OUTCOMES IN COST‐EFFECTIVENESS ANALYSES

O. Ciani and R. S. Taylor

Health Economics, 2013, vol. 22, issue 2, 251-252

Abstract: We comment on a recent article by Hawkins et al. presenting different analytic approaches for the inclusion of surrogate and final outcomes in cost‐effectiveness analyses. This methodological case study provides a timely and valuable contribution to build on the debate about the use of evidence based on surrogate outcomes in health technology assessment. Copyright © 2012 John Wiley & Sons, Ltd.

Date: 2013
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1002/hec.2826

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:22:y:2013:i:2:p:251-252

Access Statistics for this article

Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().